2019 Spina Bifida Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

April 2019 | 45 pages | ID: 22FCCD9B210EN
VPAResearch

Abstracts

The global clinical trial report- “2019 Spina Bifida Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Spina Bifida. It presents in-depth analysis of Spina Bifida clinical trials across markets and companies. The research work is for providing complete understanding into trends in Spina Bifida.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Spina Bifida clinical trials by-

• Current Trial Status
• Type of the trial
• Sponsor Type
• Enrollment Trends
• Region
• Countries
• Trial Phase

The report also identifies the potential drug candidates under development for treatment of Spina Bifida

The research work is prepared through extensive and continuous research on Spina Bifida trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:

• All major trials from 2010 to 2019 and planned trials are included in the report scope.
• Drug candidates currently being researched for administering Spina Bifida patients are identified
• The report includes panorama of Spina Bifida clinical trials across the globe
• Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
• Companies and universities focusing on Spina Bifida clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
• Average Enrollment number, insights into enrollment trends, company wise enrollment are included
• Both interventional and observational studies are analyzed
• News and latest developments for the past one year are presented in the report

Contents

1. TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2. EXECUTIVE SUMMARY

2.1 Spina Bifida Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
  2.2.1 Spina Bifida Clinical Trials by Region
  2.2.2 Average Enrollment of Spina Bifida Clinical Trials
  2.2.3 Companies participating in Trials
  2.2.4 Drugs under Study for Spina Bifida Treatment, 2019

3. REGION WISE SPINA BIFIDA CLINICAL TRIALS

3.1 Asia Pacific Spina Bifida Clinical Trials by Country
3.2 Europe Spina Bifida Clinical Trials by Country
3.3 North America Spina Bifida Clinical Trials by Country
3.4 Middle East and Africa Spina Bifida Clinical Trials by Country
3.5 South and Central America Spina Bifida Clinical Trials by Country

4. SPINA BIFIDA CLINICAL TRIAL TRENDS

4.1 Start Year wise Spina Bifida Clinical Trials
4.2 Phase wise Spina Bifida Clinical Trials
4.3 Trial Status wise Spina Bifida Clinical Trials
4.4 Trial Type wise Spina Bifida Clinical Trials

5. SPINA BIFIDA AVERAGE ENROLLMENT TRENDS

5.1 Average Enrollment in Spina Bifida Trials by Year
5.2 Average Enrollment in Spina Bifida Trials by Phase
5.3 Average Enrollment in Spina Bifida Trials by Status
5.4 Average Enrollment in Spina Bifida Trials by Type of Trial

6. COMPANIES PARTICIPATING IN SPINA BIFIDA CLINICAL TRIALS

6.1 Spina Bifida Trials by Sponsor Type
6.2 Spina Bifida Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS

7.1 Spina Bifida Trials- Phase
7.2 Spina Bifida Trials- Phase
7.3 Spina Bifida Trials- Phase
7.4 Spina Bifida Trials- Phase

8. APPENDIX

8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List Of Figures

LIST OF FIGURES

Figure 1: Spina Bifida Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Spina Bifida Clinical Trials and Enrolment
Figure 5: Europe – Country wise Spina Bifida Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Spina Bifida Clinical Trials and Enrolment
Figure 7: North America – Country wise Spina Bifida Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Spina Bifida Clinical Trials and Enrolment
Figure 9: Spina Bifida Clinical Trials by Phase
Figure 10: Spina Bifida Clinical Trials by Trial Status
Figure 11: Spina Bifida Clinical Trials by Type
Figure 12: Spina Bifida Clinical Trials by Sponsor Type
Figure 13: Spina Bifida Clinical Trials by Leading Sponsors
Figure 14: Spina Bifida Average Enrollment by Phase
Figure 15: Spina Bifida Average Enrollment by Trial Status
Figure 16: Spina Bifida Average Enrollment by Type
Figure 17: Spina Bifida- Average Enrolment by Type of Sponsors
Figure 18: Spina Bifida- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List Of Tables

LIST OF TABLES

Table 1: Spina Bifida Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Spina Bifida Clinical Trials and Enrolment
Table 5: Europe – Country wise Spina Bifida Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Spina Bifida Clinical Trials and Enrolment
Table 7: North America – Country wise Spina Bifida Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Spina Bifida Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Spina Bifida Average Enrollment by Phase
Table 15: Spina Bifida Average Enrollment by Trial Status
Table 16: Spina Bifida Average Enrollment by Type
Table 17: Spina Bifida- Average Enrolment by Type of Sponsors
Table 18: Spina Bifida- Enrolment by Leading Sponsors